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Background: Prospective access ﬂow measurement is the preferred method for
vascular access surveillance in hemodialysis (HD) patients. We studied the effect of
intradialytic change in blood pressure and ultraﬁltration volume on the variation
in access ﬂow measured by ultrasound dilution.
Methods: Access ﬂow was measured 30 minutes, 120 minutes, and 240 minutes
after the start of HD by ultrasound dilution in 30 patients during 89 HD sessions
and evaluated for variation.
Results: The mean age of the 30 patients was 62711 years: 19 were male. The
accesses comprised 16 ﬁstulae and 14 grafts. The mean access ﬂow over all sessions
decreased by 6.1% over time (12657568mL/min after 30minutes, 12607599mL/min
after 120 minutes, and 11977576 mL/min after 240 minutes, Po0.01 by repeated
measures ANOVA). In addition, aZ5% decrease in mean arterial pressure during HD
signiﬁcantly reduced access ﬂow (P¼0.014). However, no other variable (ultraﬁltra-
tion volume, sex, age, presence of diabetes, type or location of access, body surface
area, hemoglobin, serum albumin level) interacted signiﬁcantly with the effect of
time on access ﬂow. Furthermore, mean arterial pressure did not correlate with
ultraﬁltration volume.
Conclusion: We conclude that the variation in access ﬂow during HD is relatively
small. Decreased blood pressure is a risk factor for variation in access ﬂowmeasured
by ultrasound dilution. In most patients whose blood pressures are stable during HD,
the access ﬂow can be measured at any time during the HD treatment.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
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Periodic vascular access monitoring and surveillance can
predict the presence of vascular access stenosis and subsequent
thrombosis in patients undergoing hemodialysis (HD) [1]. Pre-
emptive intervention to correct stenosis of the failing access
prevents thrombosis and extends the life span of the vascularublished by Elsevier. This is an open access article under the CC BY-NC-
Park et al / Variation of access ﬂow in HD 17access in comparison with an attempted repair after a thrombotic
event [2,3], although this issue has become controversial [4].
National Kidney Foundation Kidney Disease Outcome Quality
Initiative (NKF-KDOQI) [5] and European best practice guidelines
[6] recommend prospective surveillance of ﬁstulae and grafts
together with physical examination on a regular basis, and also
recommend angiography and prompt preemptive intervention to
correct stenosis, which may improve patency rates and may
decrease the incidence of thrombosis. In addition, both guidelines
recommend monthly measurement of access ﬂow as the pre-
ferred tool for surveillance of ﬁstulae and grafts. A decreased rate
of access ﬂow has been shown to be a signiﬁcant predictor of
vascular stenosis and subsequent thrombosis for both ﬁstulae
and grafts [7–9].
Measurement of access ﬂow using the ultrasound dilution
technique has been described by Krivitski and is a reliable
method for screening for access dysfunction [10]. Its advan-
tages over Doppler ultrasound are its reproducibility, low cost,
operator-independence, and ability to provide rapid feedback
before and after corrective intervention [11,12].
A clinically controversial issue that has been raised in regard
to the measurement of access ﬂow by ultrasound dilution is the
variation in access ﬂow according to the time of measurement
during HD. The NKF-KDOQI guidelines recommend that the ﬂow
assessment should be performed during the ﬁrst 1.5 hours of the
treatment to eliminate error caused by decrease in cardiac output
or blood pressure related to ultraﬁltration and/or hypotension [5].
Restriction of the measurement time to within the ﬁrst 1.5 hours
of the treatment limits the number of measurements that can be
performed by one operator, which is a signiﬁcant issue in clinical
practice, considering the number of patients who require pro-
spective monthlymeasurement of access ﬂow. However, whether
the ultraﬁltration volume signiﬁcantly alters the access ﬂow
remains controversial [13].
The aim of this study was to evaluate whether access ﬂow
could be signiﬁcantly reduced when measured late during HD.
In addition, we evaluated whether high ultraﬁltration volume
or decrease in blood pressure at the end of HD could signiﬁ-
cantly reduce access ﬂow. Overall, we evaluated whether access
ﬂow should be measured early during HD, or it could be
measured at anytime during HD. The effect of patients’ demo-
graphic parameters on the access ﬂow was also evaluated.Methods
Patients
Thirty patients undergoing chronic HD were enrolled. Inclu-
sion criteria were patients on a three times per week HD schedule
for longer than 3 months, age 18–74 years, interdialytic weight
gain 41.0 kg, button-hole needle users in patients having ﬁstulae
for their vascular access, and ability to provide consent. Exclu-
sion criteria were predialysis systolic blood pressure in supine
position o90 mmHg, delivered blood ﬂow rate for dialysis
o300 mL/min, access ﬂow o400 mL/min in ﬁstulae, access
ﬂow o600 mL/min in grafts, and expected need for blood
transfusions during the study. The blood pump ﬂow rate was
set at 300 mL/min, and the session time was 4 hours. For
puncture, using 15-gauge needles, the rope ladder technique
was used for grafts and button-hole needles were inserted to
the ﬁstulae to maintain the same needle site and direction. All
patients provided informed consent to participation beforestudy entry. The study protocol complies with the Declaration
of Helsinki and was approved by the institutional review board
of Seoul St. Mary’s Hospital (KC10OISE0647).
Study design
In this prospective observational study, access ﬂow was
measured 30 minutes, 120 minutes, and 240 minutes after the
start of the HD session. Access ﬂow was measured in three
consecutive sessions in 29 patients, and in two consecutive
sessions in one patient. Therefore, a total of 267 measurements
of access ﬂow during 89 HD sessions were analyzed.
Access ﬂow measurement
Access ﬂow was measured by ultrasound dilution using a
Transonic HD03 HD monitor (Transonic Systems, Inc., Ithaca,
NY, USA) as previously described [10]. Brieﬂy, the dialyzer
blood pump was stopped, and the dialysis lines were reversed
from their normal conﬁguration. Two ultrasound dilution
sensors were clamped onto the bloodlines, one on the arterial
line and one on the venous line. While the blood pump ﬂow
rate was returned to 300 mL/minute, a bolus of isotonic saline
(indicator) was injected into the venous drip chamber. The
Transonic software automatically calculated the access ﬂow
from the measurements from the two sensors.
The blood pressure was recorded every hour during HD.
The body surface area, hemoglobin and serum albumin levels
were measured at the 1st day of measurement of access ﬂow.
Statistical analysis
Data are presented as mean7standard deviation (SD). The
variation in access ﬂow over time (after 30minutes, 120minutes
and 240 minutes of HD) was analyzed using repeated measures
ANOVA. The reproducibility of access ﬂow at the indicated time
of HD was analyzed by an intraclass correlation coefﬁcient. The
interactions between the effects of time and other variables on
access ﬂow were determined by two-way mixed-effects repeated
measures ANOVA. Pearson correlation coefﬁcients (r values) were
used to determine the relationships between access ﬂow and
ultraﬁltration volume or blood pressure. Differences were con-
sidered statistically signiﬁcant when the P-value was o0.05. The
SAS system for Windows (Version 9.2) was used for all analyses.Results
Patient characteristics
The 30 patients included 19 men and 11 women with a
mean7SD age of 62711 years. There were 12 (40%) diabetics.
The vascular accesses included 16 (53%) ﬁstulae and 14 (47%)
grafts and half were located in the forearm. Seventeen patients
(57%) were undergoing conventional hemodialysis, and 13
patients (43%) hemodiaﬁltration. The body surface area of the
patients was 1.5970.13 m2, and the ultraﬁltration volume/HD
session was 2.6470.92 L (Table 1). No clinical event of
vascular access dysfunction occurred during the study.
Variation of access ﬂow over time
The mean access ﬂow over all 89 sessions decreased over
time (12657568 mL/min after 30 minutes, 12607599 mL/
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utes, Po0.01). Multiple comparisons, showed that access ﬂow
was signiﬁcantly lower after 240 minutes than after 30 min-
utes or 120 minutes. The access ﬂow decreased on average by
68 mL/min in absolute value and by 6.1% in relative value
(Fig. 1).
Reproducibility of access ﬂow measured by ultrasound
dilution
The reproducibility of access ﬂow measured 30 minutes,
120 minutes, and 240 minutes after the start of the HD on the
three consecutive HD sessions was analyzed by intraclass
correlation coefﬁcient. The coefﬁcient was 0.906 after 30minutes,
0.909 after 120minutes, and 0.927 after 240min, showing that
measurement of access ﬂow by ultrasound dilution was highly
reproducible.Figure 1. Access ﬂow measured by ultrasound dilution 30 min,
120 min, and 240 minutes after start of hemodialysis. Data are
presented as the mean7standard error of the mean. P¼0.0001 by
repeated measures ANOVA. *Po0.01 vs. 30 minutes and 120 minutes
by multiple comparisons.
Table 2. Interactions between the effects of the difference in mean ar
(30 min, 120 minutes, and 240 minutes after the start of HD) on access
Group MAP (mmHg)
Pre-HD 240 min 30
Decreased (MAPZ5%; n¼28) 95.5711.0 82.3710.2 10
Nondecreased (MAPo5%; n¼61) 91.2711.3 98.3713.0 10
Table 1. Patient characteristics at the start of the study
Variable Value
Number of patients 30
Male, n (%) 19 (63.3)
Age (y) 62711
Diabetes mellitus, n (%) 12 (40)
Type of access
Fistulae, n (%) 16 (53.3)
Grafts, n (%) 14 (46.7)
Location of access
Forearm, n (%) 15 (50.0)
Upper arm, n (%) 15 (50.0)
Age of access (mo) 53749
Dialysis treatment
Conventional hemodialysis, n (%) 17 (56.7)
Hemodiaﬁltration, n (%) 13 (43.3)
Body surface area (m2) 1.5970.13
Hemoglobin (g/L) 10979.0
Serum albumin (g/L) 3873.0The interaction between the effects of time and blood
pressure on access ﬂow
To determine if a decrease in blood pressure affected
access ﬂow, we compared the access ﬂow between the
sessions in which the mean arterial pressure (MAP) measured
after 240 min had decreased by Z5% compared with pre-HD
MAP and sessions in which the MAP did not decrease by Z5%
(represented as the decreased MAP group versus the non-
decreased MAP group; Table 2). Repeated measures ANOVA
revealed that the time factor signiﬁcantly affected access ﬂow
(Po0.001), which decreased over time. AZ5% decrease in
MAP, reduced access ﬂow by 12.3%. With regard to a group
effect, the access ﬂow was signiﬁcantly lower in the decreased
MAP group than in the non-decreased MAP group (P¼0.008).
In addition, there was a signiﬁcant interaction between the
effects of time and MAP group on access ﬂow (P¼0.014),
which suggested that the decrease in blood pressure during
HD affected access ﬂow.
The interactions between access ﬂow and other variables
The interactions were next analyzed between access ﬂow
and other variables, including ultraﬁltration volume, sex, age,
presence of diabetes, type and location of access, body surface
area, and hemoglobin and serum albumin levels. Analysis
of the access ﬂow based on the ultraﬁltration volume (o2 L
vs.Z2 L or o3 L vs. Z3 L) showed no signiﬁcant interaction
between the effects of time and ultraﬁltration volume on
access ﬂow (Table 3). In addition, there were no signiﬁcant
interactions between the effects of time and any of other
variables including sex, age, presence of diabetes mellitus,
type and location of access, body surface area, hemoglobin
and serum albumin levels.
Correlation between change in MAP and ultraﬁltration
volume
To determine whether a large ultraﬁltration volume
decreased blood pressure, we examined the correlation
between the change in MAP during HD and ultraﬁltration
volume. The MAP did not correlate with the ultraﬁltration
volume in the total group of sessions (P¼0.997) or in the
subanalysis of the sessions in which the MAP was Z5% lower
after 240 minutes than pre-HD (P¼0.949).Discussion
In this study, we found the variation in access ﬂow during
HD to be relatively small (6.1%). The NKF-KDOQI guidelines on
access ﬂow surveillance clearly recommend prospective trend
analysis based on monthly measurement rather thanterial pressure (MAP) after 240 min of hemodialysis (HD) and time
ﬂow
Access ﬂow (% change) P
min 120 min 240 min
0 94.3711.6 87.7713.1 Time effect o0.001
0 101.0713.5 96.7716.7 Group effect 0.008
TimeGroup effect 0.014
Table 3. Interactions between the effects of ultraﬁltration (UF) volume and time (30 min, 120 min, and 240 minutes after the start of
hemodialysis) on access ﬂow
Variables Group Time: access ﬂow (% change) P
30 min 120 min 240 min TimeGroup effect
UF volume o2 L (n¼27) 100 98.5713.1 94.4717.7 0.915
Z2 L (n¼62) 100 99.1713.4 99.1715.5
UF volume o3 L (n¼65) 100 99.4714.3 95.0716.3 0.480
Z3 L (n¼24) 100 95.0716.3 90.9715.5
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patient should be referred for angiography when the access
ﬂow in the graft has decreased by 425% over a 4-month
period [5].
As clinical decisions are usually based on reductions of access
ﬂow by 425%, the 6.1% variation in access ﬂow during HD is
relatively small and clinically insigniﬁcant.
The change in MAP during HD did not correlate with the
variation in access ﬂow in the total group of sessions, because
the MAP measured before HD, and 30 minutes, 120 minutes,
and 240 minutes after the start of the HD session was not
different. We next compared the access ﬂow between the
sessions in which the MAP measured after 240 min had
decreased by Z5% or 10% compared with pre-HD MAP and
sessions in which the MAP did not decrease by Z5% or 10%.
We found that aZ5% decrease in MAP during HD reduced
access ﬂow after 240 min by an average of 12.3%, and this
reduction was statistically signiﬁcant. AZ10% decrease in
MAP during HD also signiﬁcantly reduced access ﬂow. Based
on our results, we would recommend that any signiﬁcantly
decreased measurement of access ﬂow in a patient in whom
MAP had decreased by Z5% should be rechecked at the next
session. Krivitski [14] similarly recommended that if a sig-
niﬁcant decrease in MAP had been observed, the clinician
should conﬁrm any reduction in access ﬂow by repeating the
measurement at the next session before referring the patient
for angiography. Rehman et al. measured access ﬂow serially
30 minutes, 90 min, and 150 min after the start of HD and
found a strong correlation between access ﬂow and the MAP
90 min after the initiation of HD, with each 10% decrease in
MAP resulting in an 8% decrease in access ﬂow [15]. They
concluded that access ﬂow could be measured up to 2–2.5 h
after the start of HD and suggested postponing measurement
in patients in whom MAP had decreased more than 15%. By
contrast, Agharazii et al. [13] found that the measurements of
access ﬂow made within the ﬁrst and last 30 min of HD in 50
patients did not differ. The access ﬂow decreased by 11.7%
over the course of the HD session, but this reduction dropped
to 4.9% when the access ﬂows were corrected for a MAP
of 100 mmHg using the following equation: Qac’¼Qac (100/
MAP), where Qac’ is the corrected access ﬂow and MAP is the
actual mean arterial pressure at the time of measurement.
They concluded that the variation in access ﬂow during HD
was relatively small, especially when the values were cor-
rected for MAP. Therefore, access ﬂow can be measured by the
ultrasound dilution method at any time during HD.
In our study, the ultraﬁltration volume did not affect access
ﬂow during HD. In addition, it was not correlated with the
change in MAP. A net reduction in the effective circulating
plasma volume due to an imbalance between the ultraﬁltrationrate and the plasma reﬁlling rate has been shown to induce
intradialytic hypotension during HD. However, intradialytic
hypotension is caused not only by the reduced circulating
plasma volume but also by the impaired physiologic adapta-
tion to the reduced plasma volume by means of constriction of
resistance vessels, increased heart rate and myocardial con-
tractility, and constriction of capacitance vessels [16,17].
Recently, an automatic biofeedback system for controlling
blood volume changes during HD has been studied in
hypotension-prone HD patients. This system is based on the
concept of blood volume tracking to prevent hypovolemia and
works by continuous modiﬁcation of the ultraﬁltration rate
and dialysate conductivity. In the studies, the use of blood
volume controlled HD reduced the frequency of intradialytic
hypotensive episodes by 30–50% in comparison with conven-
tional HD [18–20]. These results clearly demonstrate that
ultraﬁltration volume is not the only cause of hypotension
during HD. Therefore, ultraﬁltration volume might not be an
independent risk factor for either the decrease in blood
pressure or the variation in access ﬂow during HD.
Measurement of access ﬂow by ultrasound dilution takes
at least 10 min. As we are well aware of the importance of
monthly vascular access surveillance, measuring the access
ﬂow only within the initial 1.5 h of HD, in accordance with the
NKF-KDOQI guidelines, requires a greater number medical
personnel to measure access ﬂow in all patients and results in
higher medical expenses.
The limitations of this study include the small number of
patients. Because this was prospective observational study,
we did not decide the number of patients based on the
statistical sample size evaluation. Thirty patients were not
enough to conﬁrm the effect of the parameters measured in
this study on the variation in the access ﬂow during HD.
In conclusion, access ﬂow measurement by the ultrasound
dilution method is very reproducible, and the variation in access
ﬂow during HD (6.1%) is relatively small, as clinical decisions for
vascular access dysfunction requiring angiography are usually
based on reductions of access ﬂow by 425%. Because decreased
blood pressure during HD (MAP reduction by 45%) is a risk
factor for reduced access ﬂow, any clinically signiﬁcant reduc-
tion in access ﬂow in patients in whom MAP has also decreased
should be conﬁrmed at the next HD session. However, in most
patients whose blood pressures remain stable during HD, access
ﬂow can be measured at any time during the HD treatment.Conﬂicts of interest
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